BFC Planning’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
BFC Planning's PRAX Position: Q3 2026 in Review
BFC Planning increased its Praxis Precision Medicines (PRAX) stake by 350% in Q3 2026, buying an estimated $2.32K and bringing the position to 9 shares worth $2.62K. The position accounts for ﹤0.01% of the portfolio, ranked #2927.
BFC Planning first reported a position in PRAX in Q3 2025 and has held it in 3 quarters since. 237 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.
- BFC Planning held 9 shares of Praxis Precision Medicines worth $2.62K as of Q3 2026.
- BFC Planning bought 7 Praxis Precision Medicines shares in Q3 2026, an estimated $2.32K.
- Praxis Precision Medicines made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2927 holding.
- BFC Planning first reported a position in Praxis Precision Medicines in Q3 2025 and has held it in 3 quarters since.
- 237 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.